LB Pharmaceuticals Common Stock
LBRX | NASDAQ
$42.48
-$0.51 (-1.19%)
At close: Sep 22, 2026, 3:56 PM ET
$43.79
+$0.80 (+1.86%)
Pre-market:
Sep 22, 2026, 9:25 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 97K | 82K | n/a | n/a | n/a | n/a | 5K | n/a | n/a |
Gross Profit | -97K | -82K | n/a | n/a | n/a | n/a | -5K | n/a | n/a |
Operating Income | -53.92M | -22.1M | -13.87M | -5.25M | -5.64M | -5.64M | -16.08M | -26.58M | -16.63M |
Interest Income | 2.97M | 2.85M | 2.8M | 707K | 177K | 236K | 384K | 411K | 628K |
Pretax Income | -51.6M | -19.05M | -11.47M | -3.56M | -5.09M | -5.09M | -14.18M | -27.7M | -16.15M |
Net Income | -51.6M | -19.05M | -11.47M | -3.56M | -5.09M | -5.09M | -14.18M | -27.7M | -16.15M |
Selling & General & Admin | 9.67M | 7.38M | 5.39M | 2.83M | 2.62M | 2.62M | 5.41M | 2.12M | 957K |
Research & Development | 44.15M | 14.65M | 8.48M | 2.42M | 2.92M | 2.92M | 10.66M | 24.46M | 15.67M |
Other Expenses | n/a | n/a | n/a | n/a | 100K | 100K | n/a | n/a | n/a |
Operating Expenses | 53.82M | 22.02M | 13.87M | 5.25M | 5.64M | 5.64M | 16.08M | 26.58M | 16.63M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 141.5K | 141.5K | n/a | n/a | n/a |
Cost & Expenses | 53.92M | 22.1M | 13.87M | 5.25M | 5.64M | 5.64M | 16.08M | 26.58M | 16.63M |
Income Tax Expense | n/a | n/a | 1K | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 30.14M | 28.24M | 25.3M | 25.3M | 251K | 251K | 22.44M | 3.54M | 3.54M |
Shares Outstanding (Diluted) | 30.14M | 28.24M | 25.3M | 25.3M | 251.79K | 251.79K | 22.44M | 3.54M | 3.54M |
EPS (Basic) | -1.71 | -0.67 | -0.45 | -0.14 | -20.21 | -20.21 | -0.63 | -7.82 | -4.56 |
EPS (Diluted) | -1.71 | -0.67 | -0.45 | -0.14 | -20.21 | -20.21 | -0.63 | -7.82 | -4.56 |
EBITDA | -53.82M | -18.97M | -11.39M | -3.48M | -5.22M | -5.22M | -14.18M | -27.05M | -16.15M |
EBIT | -53.92M | -19.05M | -11.47M | -3.56M | -5.29M | -5.29M | -14.18M | -27.05M | -16.15M |
Depreciation & Amortization | 97K | 82K | 85K | 81K | 77.5K | 77.5K | 5K | 3K | 3K |
Add to Watchlist
Select watchlists to add or remove LBRX